Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)].
Tatsch K, Buchert R, Bartenstein P, Barthel H, Boecker H, Brust P, Drzezga A, la Fougère C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Langen KJ, Rominger A, Sabri O, Schreckenberger M, Meyer PT. Tatsch K, et al. Among authors: grunder g. Nuklearmedizin. 2019 Feb;58(1):5-16. doi: 10.1055/a-0807-8137. Epub 2019 Feb 15. Nuklearmedizin. 2019. PMID: 30769368 German.
[German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].
Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, Coenen HH, la Fougère C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Schreckenberger M, Tatsch K, Langen KJ, Sabri O. Barthel H, et al. Among authors: grunder g. Nuklearmedizin. 2016 Aug 5;55(4):129-37. doi: 10.3413/Nukmed-0816-16-04. Epub 2016 Apr 15. Nuklearmedizin. 2016. PMID: 27080914 German.
The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F, Gründer G, Bartenstein P, Vogt T. Schreckenberger M, et al. Among authors: grunder g. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1128-35. doi: 10.1007/s00259-004-1465-5. Epub 2004 Mar 23. Eur J Nucl Med Mol Imaging. 2004. PMID: 15042325 Clinical Trial.
Opioid receptor PET reveals the psychobiologic correlates of reward processing.
Schreckenberger M, Klega A, Gründer G, Buchholz HG, Scheurich A, Schirrmacher R, Schirrmacher E, Müller C, Henriksen G, Bartenstein P. Schreckenberger M, et al. Among authors: grunder g. J Nucl Med. 2008 Aug;49(8):1257-61. doi: 10.2967/jnumed.108.050849. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632824 Free article.
Acute alcohol effects on neuronal and attentional processing: striatal reward system and inhibitory sensory interactions under acute ethanol challenge.
Schreckenberger M, Amberg R, Scheurich A, Lochmann M, Tichy W, Klega A, Siessmeier T, Gründer G, Buchholz HG, Landvogt C, Stauss J, Mann K, Bartenstein P, Urban R. Schreckenberger M, et al. Among authors: grunder g. Neuropsychopharmacology. 2004 Aug;29(8):1527-37. doi: 10.1038/sj.npp.1300453. Neuropsychopharmacology. 2004. PMID: 15085090 Clinical Trial.
Dopamine D2/D3 receptor availability and venturesomeness.
Bernow N, Yakushev I, Landvogt C, Buchholz HG, Smolka MN, Bartenstein P, Lieb K, Gründer G, Vernaleken I, Schreckenberger M, Fehr C. Bernow N, et al. Among authors: grunder g. Psychiatry Res. 2011 Aug 30;193(2):80-4. doi: 10.1016/j.pscychresns.2011.01.011. Psychiatry Res. 2011. PMID: 21689908
Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
Heinz A, Siessmeier T, Wrase J, Buchholz HG, Gründer G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rösch F, Mann K, Bartenstein P. Heinz A, et al. Among authors: grunder g. Am J Psychiatry. 2005 Aug;162(8):1515-20. doi: 10.1176/appi.ajp.162.8.1515. Am J Psychiatry. 2005. PMID: 16055774
251 results